Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05005273
Title	A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Bristol-Myers Squibb
Indications	lung non-small cell carcinoma
Therapies	Ipilimumab + Nivolumab BMS-986207 + Ipilimumab + Nivolumab
Age Groups:	adult \| senior
Covered Countries	USA \| ITA \| FRA \| ESP \| DEU \| BEL \| AUS